Treating people for hepatitis C infection reduces risk of cirrhosis, liver cancer, and overall mortality in the future.
A new study looks at the risk of developing hepatocellular carcinoma (HCC) among patients who have been cured of the hepatitis C virus.
Researchers at Baylor College of Medicine in Houston found that patients who were cured of the hepatitis C virus after undergoing treatment had reduced risk of developing HCC, especially when treated before cirrhosis develops, according to a Baylor news release. The findings of the study were published in April in the journal Hepatology.
Chronic infection of the hepatitis C virus can seriously damage the liver over time and lead to cirrhosis of the liver, liver cancer and the need for liver transplant. The virus is a strong risk factor for HCC, the most common type of primary liver cancer, the release notes.
“With the advent of new highly effective medications for treating hepatitis C, we expect to see a lot of people cured of the disease,” lead author Hashem El-Serag, MD, chief of gastroenterology and hepatology at Baylor and at the Michael E. DeBakey Veterans Affairs Medical Center, stated in the release. “However, we did not have good information about what happens to these people in terms of their future risks of developing HCC after cure.”
Read Full Article: Study Examines Risk of Liver Cancer after Hepatitis C Cure
|Read Full Article: Study Examines Risk of Liver Cancer after Hepatitis C Cure|